BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pang TCY, Xu Z, Mekapogu AR, Pothula S, Becker T, Corley S, Wilkins MR, Goldstein D, Pirola R, Wilson J, Apte M. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Cancers (Basel) 2021;13:2763. [PMID: 34199452 DOI: 10.3390/cancers13112763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mortazavi M, Raufi E, Damghani T, Khoshneviszadeh M, Edraki N, Eskandari M, Giovannetti E, Peters GJ, Pirhadi S, Firuzi O. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175395] [Reference Citation Analysis]
2 Yang Z, Xie Z, Wan J, Yi B, Xu T, Shu X, Zhao Z, Tang C. Current Trends and Research Hotspots in Pancreatic Stellate Cells: A Bibliometric Study. Front Oncol 2022;12:896679. [PMID: 35719926 DOI: 10.3389/fonc.2022.896679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]